Membership Policies & Procedures

The Perlmutter Cancer Center recognizes that a productive cancer center is dedicated to meeting both scientific objectives and clinical needs of patients, which requires the full participation of both basic and clinical investigators, practicing physicians, and other healthcare providers. A critical component of the Perlmutter Cancer Center is the Cancer Center Support Grant (CCSG), which is focused on establishing scientific programs whose objectives seek to understand the origins of human cancer at a most fundamental level, and to use this information to prevent, treat, and/or ease the burden of cancer.

Member Benefits

The benefits of membership are substantial, and the National Cancer Institute (NCI) designation increases the visibility of individual members. Specific benefits include:

  1. Reduced prices for Perlmutter Cancer Center shared resources.
  2. Access to apply for developmental pilot funds, administrative support, and clinical research resources.
  3. Notification and participation in all Perlmutter Cancer Center-sponsored seminars and meetings.
  4. Listing on the Perlmutter Cancer Center Website.

Membership Responsibilities

Perlmutter Cancer Center CCSG membership is granted based on contributions to the academic mission and funding by the NCI or NCI approved peer-reviewed agencies or organizations. Ongoing membership is granted based on tangible contributions, such as the conduct of cancer-focused basic laboratory investigation; correlative biology studies linking laboratory evaluation of human tumors with clinical outcome variables; the design of innovative therapeutic protocols based on insights developed in the laboratory; population-based studies designed to determine risk and/or assessing prevention approaches; and studies dedicated to understanding barriers to effective cancer care.

Therefore, obligations of membership include:

  1. Ongoing grant support by the NCI or NCI approved peer-reviewed agencies or organizations
  2. Collaborative publications between a member's specific program and other CCSG programs within the last 3 years
  3. Active collaboration in basic, translational, or clinical research of the Perlmutter Cancer Center
  4. Participation in Disease Group meetings designed to optimize patient care and promote clinical/translational cancer research
  5. Regular involvement in educational activities of the Perlmutter Cancer Center
  6. Joining Perlmutter Cancer Center members in enhancing the visibility of the Perlmutter Cancer Center

National Cancer Institute approved peer-reviewed agencies and organizations:
(list source: http://cancercenters.cancer.gov/grants_funding/index.html January 11, 2011 guidelines)

American Foundation for AIDS Research (AFAR)

Agency for Healthcare Research and Quality (AHRQ)

American Institute for Cancer Research (AICR)

U.S. Army (DOD)

Susan G. Komen for the Cure

American Cancer Society (ACS): national office only

Central Office of the Veterans Administration (VA) - excluding local/regional awards and "block" grants

Center for Disease Control and Prevention (CDC)

Flight Attendant Medical Research Institute (FAMRI)

Environmental Protection Agency (EPA)

Food and Drug Administration (FDA)

National Science Foundation (NSF)

Leukemia and Lymphoma Society

Howard Hughes Foundation

National Institute for Occupational Safety and Health (NIOSH)

Multiple Myeloma Research Foundation

Prevent Cancer Foundation

 

 

The Cancer Centers Program also recognizes that many high quality, cancer-relevant research projects are funded by other organizations such as the Department of Energy (DOE), Department of Agriculture (DOA), the Center for Disease Control and Prevention (CDC), State Health Departments etc. With this intent in mind, multi-year projects, which are equivalent in size and scientific complexity to an NIH R01 research project and funded by other organizations not listed specifically above, can be considered for eligibility if approved by the Membership Committee. The Membership Committee may evaluate funded projects on a case by case basis using the following criteria after submitting the requested information in addition to the Membership Application:

  1. Project is a multi-year project equivalent in size and scientific complexity to an NIH R01.
  2. The project is clearly cancer relevant.

Required Information:

  • Project Leader
  • Professional Collaborators
  • Title of Project
  • Total Project Period
  • Direct Costs for Current Year
  • Funding Organization
  • Number Identifier of Funding Organization
  • Center Program Affiliation
  • Abstract of the Project (in 500 words or less describe rationale, objectives, cancer relevance and progress)